Caenorhabditis elegans as a Model Host to Monitor the Candida Infection Processes
Abstract
:1. Introduction
2. Tools and Techniques
2.1. Maintenance of C. albicans and C. elegans
2.2. Measurement of Host Lifespan Post Infection
2.3. Microscopy
3. C. elegans as a Model Host to Study Virulence of C. albicans
3.1. Using C. elegans to Study Host Innate Immunity against Fungal Pathogens
3.2. Other Host Pathways
3.3. Using C. elegans as in vivo Model to Study C. albicans Virulence Mechanisms
3.4. C. elegans as a Live Animal Model for Antifungal Drug Discovery
3.5. Studying the in vivo Evolution of C. albicans
4. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Schulenburg, H.; Felix, M.A. The Natural Biotic Environment of Caenorhabditis elegans. Genetics 2017, 206, 55–86. [Google Scholar] [CrossRef] [PubMed]
- Brenner, S. The genetics of Caenorhabditis elegans. Genetics 1974, 77, 71–94. [Google Scholar] [PubMed]
- Riddle, D.L.; Blumenthal, T.; Meyer, B.J.; Priess, J.R. Introduction to C. elegans. In C. elegans II, 2nd ed.; Riddle, D.L., Blumenthal, T., Meyer, B.J., Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 1997. [Google Scholar]
- Fire, A.; Xu, S.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391, 806–811. [Google Scholar] [CrossRef] [PubMed]
- Ellis, H.M.; Horvitz, H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986, 44, 817–829. [Google Scholar] [CrossRef]
- Hengartner, M.O.; Ellis, R.E.; Horvitz, H.R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992, 356, 494–499. [Google Scholar] [CrossRef] [PubMed]
- Sulston, J.E.; Horvitz, H.R. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev. Biol. 1977, 56, 110–156. [Google Scholar] [CrossRef]
- Chalfie, M.; Tu, Y.; Euskirchen, G.; Ward, W.W.; Prasher, D.C. Green fluorescent protein as a marker for gene expression. Science 1994, 263, 802–805. [Google Scholar] [CrossRef] [PubMed]
- Ruijtenberg, S.; Van Den Heuvel, S. G1/S Inhibitors and the SWI/SNF Complex Control Cell-Cycle Exit during Muscle Differentiation. Cell 2015, 162, 300–313. [Google Scholar] [CrossRef] [PubMed]
- Lehmann, S.; Bass, J.J.; Szewczyk, N.J. Knockdown of the C. elegans Kinome identifies Kinases required for normal protein Homeostasis, Mitochondrial network structure, and Sarcomere structure in muscle. Cell Commun. Signal. 2013, 11, 1. [Google Scholar] [CrossRef] [PubMed]
- Ono, S. Regulation of structure and function of sarcomeric actin filaments in striated muscle of the nematode Caenorhabditis elegans. Anat. Rec. 2014, 297, 1548–1559. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.; Chin-Sang, I.D.C. C. elegans as a model to study PTEN’s regulation and function. Methods 2015, 77, 180–190. [Google Scholar] [CrossRef] [PubMed]
- Tan, M.W.; Mahajan-Miklos, S.; Ausubel, F.M. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. USA 1999, 96, 715–720. [Google Scholar] [CrossRef] [PubMed]
- Irazoqui, J.E.; Troemel, E.R.; Feinbaum, R.L.; Luhachack, L.G.; Cezairliyan, B.O.; Ausubel, F.M. Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog. 2010, 6, 1–24. [Google Scholar] [CrossRef] [PubMed]
- Kaletta, T.; Hengartner, M.O. Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 2006, 5, 387–398. [Google Scholar] [CrossRef] [PubMed]
- Kong, C.; Yehye, W.A.; Abd Rahman, N.; Tan, M.W.; Nathan, S. Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model. BMC Complement. Altern. Med. 2014, 14, 4. [Google Scholar] [CrossRef] [PubMed]
- Marsh, E.K.; May, R.C. Caenorhabditis elegans, a model organism for investigating immunity. Appl. Environ. Microbiol. 2012, 78, 2075–2081. [Google Scholar] [CrossRef] [PubMed]
- Sem, X.; Rhen, M. Pathogenicity of Salmonella enterica in Caenorhabditis elegans relies on disseminated oxidative stress in the infected host. PLoS ONE 2012, 7. [Google Scholar] [CrossRef] [PubMed]
- Sifri, C.D.; Begun, J.; Ausubel, F.M.; Calderwood, S.B. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect. Immun. 2003, 71, 2208–2217. [Google Scholar] [CrossRef] [PubMed]
- Mylonakis, E.; Ausubel, F.M.; Perfect, J.R.; Heitman, J.; Calderwood, S.B. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc. Natl. Acad. Sci. USA 2002, 99, 15675–15680. [Google Scholar] [CrossRef] [PubMed]
- Mylonakis, E.; Idnurm, A.; Moreno, R.; El Khoury, J.; Rottman, J.B.; Ausubel, F.M.; Heitman, J.; Calderwood, S.B. Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol. Microbiol. 2004, 54, 407–419. [Google Scholar] [CrossRef] [PubMed]
- Van den Berg, M.C.; Woerlee, J.Z.; Ma, H.; May, R.C. Sex-dependent resistance to the pathogenic fungus Cryptococcus neoformans. Genetics 2006, 173, 677–683. [Google Scholar] [CrossRef] [PubMed]
- Pukkila-Worley, R.; Peleg, A.Y.; Tampakakis, E.; Mylonakis, E. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot. Cell 2009, 8, 1750–1758. [Google Scholar] [CrossRef] [PubMed]
- Pukkila-Worley, R.; Ausubel, F.M.; Mylonakis, E. Candida albicans infection of caenorhabditis elegans induces antifungal immune defenses. PLoS Pathog. 2011, 7. [Google Scholar] [CrossRef] [PubMed]
- Jain, C.; Pastor, K.; Gonzalez, A.Y.; Lorenz, M.C.; Rao, R.P. The role of Candida albicans AP-1 protein against host derived ROS in in vivo models of infection. Virulence 2013, 4, 67–76. [Google Scholar] [CrossRef] [PubMed]
- Issi, L.; Rioux, M.; Rao, R. The Nematode Caenorhabditis Elegans—A Versatile In Vivo Model to Study Host-microbe Interactions. J. Vis. Exp. 2017. [Google Scholar] [CrossRef] [PubMed]
- Desalermos, A.; Tan, X.; Rajamuthiah, R.; Arvanitis, M.; Wang, Y.; Li, D.; Kourkoumpetis, T.K.; Fuchs, B.B.; Mylonakis, E. A multi-host approach for the systematic analysis of virulence factors in Cryptococcus neoformans. J. Infect. Dis. 2015, 211, 298–305. [Google Scholar] [CrossRef] [PubMed]
- Desalermos, A.; Fuchs, B.B.; Mylonakis, E. Selecting an invertebrate model host for the study of fungal pathogenesis. PLoS Pathog. 2012, 8, 8–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bae, T.; Banger, A.K.; Wallace, A.; Glass, E.M.; Aslund, F.; Schneewind, O.; Missiakas, D.M. Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc. Natl. Acad. Sci. USA 2004, 101, 12312–12317. [Google Scholar] [CrossRef] [PubMed]
- Kim, D.H.; Feinbaum, R.; Alloing, G.; Emerson, F.E.; Garsin, D.A.; Inoue, H.; Tanaka-Hino, M.; Hisamoto, N.; Matsumoto, K.; Tan, M.W.; Ausubel, F.M. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 2002, 297, 623–626. [Google Scholar] [CrossRef] [PubMed]
- Mylonakis, E.; Aballay, A. Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infect. Immun. 2005, 73, 3833–3841. [Google Scholar] [CrossRef] [PubMed]
- Portal-Celhay, C.; Blaser, M.J. Competition and resilience between founder and introduced bacteria in the Caenorhabditis elegans gut. Infect. Immun. 2012, 80, 1288–1299. [Google Scholar] [CrossRef] [PubMed]
- Dirksen, P.; Marsh, S.A.; Braker, I.; Heitland, N.; Wagner, S.; Nakad, R.; Mader, S.; Petersen, C.; Kowallik, V.; Rosenstiel, P.; Felix, M.A.; Schulenburg, H. The native microbiome of the nematode Caenorhabditis elegans: Gateway to a new host-microbiome model. BMC Biol. 2016, 14, 38. [Google Scholar] [CrossRef] [PubMed]
- Couillault, C.; Pujol, N.; Reboul, J.; Sabatier, L.; Guichou, J.F.; Kohara, Y.; Ewbank, J.J. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat. Immunol. 2004, 5, 488–494. [Google Scholar] [CrossRef] [PubMed]
- Aballay, A.; Ausubel, F.M. Caenorhabditis elegans as a host for the study of host-pathogen interactions. Curr. Opin. Microbiol. 2002, 5, 97–101. [Google Scholar] [CrossRef]
- Aballay, A.; Drenkard, E.; Hilbun, L.R.; Ausubel, F.M. Caenorhabditis elegans innate immune response triggered by Salmonella enterica requires intact LPS and is mediated by a MAPK signaling pathway. Curr. Biol. 2003, 13, 47–52. [Google Scholar] [CrossRef]
- Kesika, P.; Balamurugan, K. Studies on Shigella boydii infection in Caenorhabditis elegans and bioinformatics analysis of immune regulatory protein interactions. Biochim. Biophys. Acta 2012, 1824, 1449–1456. [Google Scholar] [CrossRef] [PubMed]
- Aballay, A.; Yorgey, P.; Ausubel, F.M. Salmonella typhimurium proliferates and establishes a persistent infection in the intestine of Caenorhabditis elegans. Curr. Biol. 2000, 10, 1539–1542. [Google Scholar] [CrossRef]
- Cinar, H.N.; Kothary, M.; Datta, A.R.; Tall, B.D.; Sprando, R.; Bilecen, K.; Yildiz, F.; McCardell, B. Vibrio cholerae hemolysin is required for lethality, developmental delay, and intestinal vacuolation in Caenorhabditis elegans. PLoS ONE 2010, 5. [Google Scholar] [CrossRef] [PubMed]
- Jain, C.; Yun, M.; Politz, S.M.; Rao, R.P. A Pathogenesis Assay Using Saccharomyces cerevisiae and Caenorhabditis elegans Reveals Novel Roles for Yeast AP-1, Yap1, and Host Dual Oxidase BLI-3 in Fungal Pathogenesis. Eukaryot. Cell 2009, 8, 1218–1227. [Google Scholar] [CrossRef] [PubMed]
- Nobile, C.J.; Solis, N.; Myers, C.L.; Fay, A.J.; Deneault, J.S.; Nantel, A.; Mitchell, A.P.; Filler, S.G. Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell. Immunol. 2008, 1, 2180–2196. [Google Scholar]
- Ford, C.B.; Funt, J.M.; Abbey, D.; Issi, L.; Guiducci, C.; Martinez, D.A.; Delorey, T.; Li, B.Y.; White, T.C.; Cuomo, C.; Rao, R.P.; Berman, J.; Thompson, D.A.; Regev, A. The evolution of drug resistance in clinical isolates of Candida albicans. eLife 2015, 4. [Google Scholar] [CrossRef] [PubMed]
- Okoli, I.; Coleman, J.J.; Tempakakis, E.; An, W.F.; Holson, E.; Wagner, F.; Conery, A.L.; Larkins-Ford, J.; Wu, G.; Stern, A.; Ausubel, F.M.; Mylonakis, E. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS ONE 2009, 4, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Breger, J.; Fuchs, B.B.; Aperis, G.; Moy, T.I.; Ausubel, F.M.; Mylonakis, E. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 2007, 3, 168–178. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Muhammed, M.; Arvanitis, M.; Mylonakis, E. Whole animal HTS of small molecules for antifungal compounds. Expert Opin. Drug Discov. 2016, 11, 177–184. [Google Scholar] [CrossRef] [PubMed]
- Desalermos, A.; Muhammed, M.; Glavis-Bloom, J.; Mylonakis, E. Using C. elegans for antimicrobial drug discovery. Expert Opin. Drug Discov. 2011, 6, 645–652. [Google Scholar] [CrossRef] [PubMed]
- Luca, V.; Olivi, M.; Di Grazia, A.; Palleschi, C.; Uccelletti, D.; Mangoni, M.L. Anti-Candida activity of 1-18 fragment of the frog skin peptide esculentin-1b: In vitro and in vivo studies in a Caenorhabditis elegans infection model. Cell. Mol. Life Sci. 2014, 71, 2535–2546. [Google Scholar] [CrossRef] [PubMed]
- Rentz, A.M.; Halpern, M.T.; Bowden, R. The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin. Infect. Dis. 1998, 27, 781–788. [Google Scholar] [CrossRef] [PubMed]
- Wilson, L.S.; Reyes, C.M.; Stolpman, M.; Speckman, J.; Allen, K.; Beney, J. The direct cost and incidence of systemic fungal infections. Value Health 2002, 5, 26–34. [Google Scholar] [CrossRef] [PubMed]
- Wisplinghoff, H.; Bischoff, T.; Tallent, S.M.; Seifert, H.; Wenzel, R.P.; Edmond, M.B. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 2004, 39, 309–317. [Google Scholar] [CrossRef] [PubMed]
- Benedict, K.; Jackson, B.R.; Chiller, T.; Beer, K.D. Estimation of direct healthcare costs of fungal diseases in the United States. Clin. Infect. Dis. 2018. [Google Scholar] [CrossRef] [PubMed]
- Charalambous, L.T.; Premji, A.; Tybout, C.; Hunt, A.; Cutshaw, D.; Elsamadicy, A.A.; Yang, S.; Xie, J.; Giamberardino, C.; Pagadala, P.; et al. Prevalence, healthcare resource utilization and overall burden of fungal meningitis in the United States. J. Med. Microbiol. 2018, 67, 215–227. [Google Scholar] [CrossRef] [PubMed]
- Dodds Ashley, E.; Drew, R.; Johnson, M.; Danna, R.; Dabrowski, D.; Walker, V.; Prasad, M.; Alexander, B.; Papadopoulos, G.; Perfect, J. Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options. Pharmacotherapy 2012, 32, 890–901. [Google Scholar] [CrossRef] [PubMed]
- Mayer, F.L.; Wilson, D.; Hube, B. Candida albicans pathogenicity mechanisms. Virulence 2013, 4, 119–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cowen, L.E. The evolution of fungal drug resistance: Modulating the trajectory from genotype to phenotype. Nat. Rev. Microbiol. 2008, 6, 187–198. [Google Scholar] [CrossRef] [PubMed]
- Hernday, A.D.; Noble, S.M.; Mitrovich, Q.M.; Johnson, A.D. Genetics and Molecular Biology in Candida albicans. Methods Enzymol. 2010, 470, 737–758. [Google Scholar] [PubMed]
- Stiernagle, T. Maintenance of C. elegans. WormBook 2006. [Google Scholar] [CrossRef] [PubMed]
- Xiao, R.; Chun, L.; Ronan, E.A.; Friedman, D.I.; Liu, J.; Xu, X.Z. RNAi Interrogation of Dietary Modulation of Development, Metabolism, Behavior, and Aging in C. elegans. Cell. Rep. 2015, 11, 1123–1133. [Google Scholar] [CrossRef] [PubMed]
- Reddy, K.C.; Andersen, E.C.; Kruglyak, L.; Kim, D.H. A polymorphism in npr-1 is a behavioral determinant of pathogen susceptibility in C. elegans. Science 2009, 323, 382–384. [Google Scholar] [CrossRef] [PubMed]
- Chou, T.C.; Chiu, H.C.; Kuo, C.J.; Wu, C.M.; Syu, W.J.; Chiu, W.T.; Chen, C.S. Enterohaemorrhagic Escherichia coli O157:H7 Shiga-like toxin 1 is required for full pathogenicity and activation of the p38 mitogen-activated protein kinase pathway in Caenorhabditis elegans. Cell. Immunol. 2013, 15, 82–97. [Google Scholar]
- Hu, P.J. Dauer. In WormBook; Riddle, D.L., Ed.; WormBook: Pasadena, CA, USA, 2007. [Google Scholar]
- Wilkinson, D.S.; Taylor, R.C.; Dillin, A. Analysis of aging in Caenorhabditis elegans. Methods Cell Biol. 2012, 107, 353–381. [Google Scholar] [PubMed]
- Amrit, F.R.G.; Ratnappan, R.; Keith, S.A.; Ghazi, A. The C. elegans lifespan assay toolkit. Methods 2014, 68, 465–475. [Google Scholar] [CrossRef] [PubMed]
- Podbilewicz, B.; Gruenbaum, Y. Live Imaging of Caenorhabditis elegans: Preparation of Samples. Cold Spring Harb. Protoc. 2006, 2006. [Google Scholar] [CrossRef] [PubMed]
- Luke, C.J.; Niehaus, J.Z.; O’Reilly, L.P.; Watkins, S.C. Non-microfluidic methods for imaging live C. elegans. Methods 2014, 68, 542–547. [Google Scholar] [CrossRef] [PubMed]
- Gaffney, C.J.; Bass, J.J.; Barratt, T.F.; Szewczyk, N.J. Methods to Assess Subcellular Compartments of Muscle in C. elegans. J. Vis. Exp. 2014. [Google Scholar] [CrossRef] [PubMed]
- Pincus, Z.; Mazer, T.C.; Slack, F.J. Autofluorescence as a measure of senescence in C. elegans: Look to red, not blue or green. Aging 2016, 8, 889–898. [Google Scholar] [CrossRef] [PubMed]
- Husson, S.J.; Costa, W.S.; Schmitt, C.; Gottschalk, A. Keeping track of worm trackers. WormBook 2013. [Google Scholar] [CrossRef] [PubMed]
- San-Miguel, A.; Lu, H. Microfluidics as a tool for C. elegans research. WormBook 2013. [Google Scholar] [CrossRef] [PubMed]
- Kelley, L.C.; Wang, Z.; Hagedorn, E.J.; Wang, L.; Shen, W.; Lei, S.; Johnson, S.A.; Sherwood, D.R. Live-cell confocal microscopy and quantitative 4D image analysis of anchor-cell invasion through the basement membrane in Caenorhabditis elegans. Nat. Protoc. 2017, 12, 2081–2096. [Google Scholar] [CrossRef] [PubMed]
- Luke, C.J.; O’Reilly, L.P. Microscopic Investigation of Protein Function in C. elegans Using Fluorescent Imaging. Curr. Protoc. Cytom. 2015, 74. [Google Scholar] [CrossRef]
- Garsin, D.A.; Sifri, C.D.; Mylonakis, E.; Qin, X.; Singh, K.V.; Murray, B.E.; Calderwood, S.B.; Ausubel, F.M. A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. USA 2001, 98, 10892–10897. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cruz, M.R.; Graham, C.E.; Gagliano, B.C.; Lorenz, M.C.; Garsin, D.A. Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect. Immun. 2013, 81, 189–200. [Google Scholar] [CrossRef] [PubMed]
- Pujol, N.; Cypowyj, S.; Ziegler, K.; Millet, A.; Astrain, A.; Goncharov, A.; Jin, Y.; Chisholm, A.D.; Ewbank, J.J. Distinct innate immune responses to infection and wounding in the C. elegans epidermis. Curr. Biol. 2008, 18, 481–489. [Google Scholar] [CrossRef] [PubMed]
- Ziegler, K.; Kurz, C.L.; Cypowyj, S.; Couillault, C.; Pophillat, M.; Pujol, N.; Ewbank, J.J. Antifungal innate immunity in C. elegans: PKCdelta links G protein signaling and a conserved p38 MAPK cascade. Cell. Host Microbe 2009, 5, 341–352. [Google Scholar] [CrossRef] [PubMed]
- Huffman, D.L.; Abrami, L.; Sasik, R.; Corbeil, J.; van der Goot, F.G.; Aroian, R.V. Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc. Natl. Acad. Sci. USA 2004, 101, 10995–11000. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tenor, J.L.; Aballay, A. A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity. EMBO Rep. 2008, 9, 103–109. [Google Scholar] [CrossRef] [PubMed]
- Fukata, M.; Michelsen, K.S.; Eri, R.; Thomas, L.S.; Hu, B.; Lukasek, K.; Nast, C.C.; Lechago, J.; Xu, R.; Naiki, Y.; et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288, G1055-65. [Google Scholar] [CrossRef] [PubMed]
- Pujol, N.; Link, E.M.; Liu, L.X.; Kurz, C.L.; Alloing, G.; Tan, M.W.; Ray, K.P.; Solari, R.; Johnson, C.D.; Ewbank, J.J. A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr. Biol. 2001, 11, 809–821. [Google Scholar] [CrossRef]
- Mallo, G.V.; Kurz, C.L.; Couillault, C.; Pujol, N.; Granjeaud, S.; Kohara, Y.; Ewbank, J.J. Inducible antibacterial defense system in C. elegans. Curr. Biol. 2002, 12, 1209–1214. [Google Scholar] [CrossRef]
- Alper, S.; McBride, S.J.; Lackford, B.; Freedman, J.H.; Schwartz, D.A. Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol. Cell. Biol. 2007, 27, 5544–5553. [Google Scholar] [CrossRef] [PubMed]
- Murphy, C.T.; McCarroll, S.A.; Bargmann, C.I.; Fraser, A.; Kamath, R.S.; Ahringer, J.; Li, H.; Kenyon, C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 2003, 424, 277–283. [Google Scholar] [CrossRef] [PubMed]
- Murphy, C.T.; Hu, P.J. Insulin/insulin-like growth factor signaling in C. elegans. WormBook 2013. [Google Scholar] [CrossRef] [PubMed]
- Lamitina, S.T.; Strange, K. Transcriptional targets of DAF-16 insulin signaling pathway protect C. elegans from extreme hypertonic stress. Am. J. Physiol. Cell Physiol. 2005, 288, C467–C474. [Google Scholar] [CrossRef] [PubMed]
- Ewbank, J.J.; Pujol, N. Local and long-range activation of innate immunity by infection and damage in C. elegans. Curr. Opin. Immunol. 2016, 38, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the human intestinal microbial flora. Science 2005, 308, 1635–1638. [Google Scholar] [CrossRef] [PubMed]
- Hoffmann, C.; Dollive, S.; Grunberg, S.; Chen, J.; Li, H.; Wu, G.D.; Lewis, J.D.; Bushman, F.D. Archaea and fungi of the human gut microbiome: Correlations with diet and bacterial residents. PLoS ONE 2013, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Santelmann, H.; Howard, J.M. Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 2005, 17, 21–26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ince, M.N.; Elliott, D.E. Immunologic and molecular mechanisms in inflammatory bowel disease. Surg. Clin. North Am. 2007, 87, 681–696. [Google Scholar] [CrossRef] [PubMed]
- Yilmaz, L.S.; Walhout, A.J. Worms, bacteria, and micronutrients: An elegant model of our diet. Trends Genet. 2014, 30, 496–503. [Google Scholar] [CrossRef] [PubMed]
- Yilmaz, L.S.; Walhout, A.J. A Caenorhabditis elegans Genome-Scale Metabolic Network Model. Cell Syst. 2016, 2, 297–311. [Google Scholar] [CrossRef] [PubMed]
- Naglik, J.R.; Challacombe, S.J.; Hube, B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 2003, 67, 400–428. [Google Scholar] [CrossRef] [PubMed]
- Hoyer, L.L.; Fundyga, R.; Hecht, J.E.; Kapteyn, J.C.; Klis, F.M.; Arnold, J. Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS family. Genetics 2001, 157, 1555–1567. [Google Scholar] [PubMed]
- Desai, J.V.; Cheng, S.; Ying, T.; Nguyen, M.H.; Clancy, C.J.; Lanni, F.; Mitchell, A.P. Coordination of Candida albicans Invasion and Infection Functions by Phosphoglycerol Phosphatase Rhr2. Pathogens 2015, 4, 573–589. [Google Scholar] [CrossRef] [PubMed]
- Wachtler, B.; Wilson, D.; Haedicke, K.; Dalle, F.; Hube, B. From attachment to damage: Defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS ONE 2011, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Almeida, M.C.; Brand, A.C. Thigmo Responses: The Fungal Sense of Touch. Microbiol. Spectr. 2017, 5. [Google Scholar] [CrossRef]
- Aoki, W.; Kitahara, N.; Miura, N.; Morisaka, H.; Yamamoto, Y.; Kuroda, K.; Ueda, M. Comprehensive characterization of secreted aspartic proteases encoded by a virulence gene family in Candida albicans. J. Biochem. 2011, 150, 431–438. [Google Scholar] [CrossRef] [PubMed]
- Schaller, M.; Borelli, C.; Korting, H.C.; Hube, B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005, 48, 365–377. [Google Scholar] [CrossRef] [PubMed]
- Jacobsen, I.D.; Wilson, D.; Wachtler, B.; Brunke, S.; Naglik, J.R.; Hube, B. Candida albicans dimorphism as a therapeutic target. Expert Rev. Anti-Infect. Ther. 2012, 10, 85–93. [Google Scholar] [CrossRef] [PubMed]
- Lo, H.J.; Kohler, J.R.; DiDomenico, B.; Loebenberg, D.; Cacciapuoti, A.; Fink, G.R. Nonfilamentous C. albicans mutants are avirulent. Cell 1997, 90, 939–949. [Google Scholar] [CrossRef]
- Saville, S.P.; Lazzell, A.L.; Monteagudo, C.; Lopez-Ribot, J.L. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot. Cell 2003, 2, 1053–1060. [Google Scholar] [CrossRef] [PubMed]
- Finkel, J.S.; Mitchell, A.P. Genetic control of Candida albicans biofilm development. Nat. Rev. Microbiol. 2011, 9, 109–118. [Google Scholar] [CrossRef] [PubMed]
- Nobile, C.J.; Fox, E.P.; Nett, J.E.; Sorrells, T.R.; Mitrovich, Q.M.; Hernday, A.D.; Tuch, B.B.; Andes, D.R.; Johnson, A.D. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 2012, 148, 126–138. [Google Scholar] [CrossRef] [PubMed]
- Sasse, C.; Hasenberg, M.; Weyler, M.; Gunzer, M.; Morschhauser, J. White-opaque switching of Candida albicans allows immune evasion in an environment-dependent fashion. Eukaryot. Cell 2013, 12, 50–58. [Google Scholar] [CrossRef] [PubMed]
- Ramirez-Zavala, B.; Reuss, O.; Park, Y.N.; Ohlsen, K.; Morschhauser, J. Environmental induction of white-opaque switching in Candida albicans. PLoS Pathog. 2008, 4. [Google Scholar] [CrossRef] [PubMed]
- Brock, M. Fungal metabolism in host niches. Curr. Opin. Microbiol. 2009, 12, 371–376. [Google Scholar] [CrossRef] [PubMed]
- Tucey, T.M.; Verma, J.; Harrison, P.F.; Snelgrove, S.L.; Lo, T.L.; Scherer, A.K.; Barugahare, A.A.; Powell, D.R.; Wheeler, R.T.; Hickey, M.J.; et al. Glucose Homeostasis Is Important for Immune Cell Viability during Candida Challenge and Host Survival of Systemic Fungal Infection. Cell Metab. 2018, 27, 988–1006. [Google Scholar] [CrossRef] [PubMed]
- Lorenz, M.C.; Bender, J.A.; Fink, G.R. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 2004, 3, 1076–1087. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Xu, X.L. Bacterial peptidoglycan-derived molecules activate Candida albicans hyphal growth. Commun. Integr. Biol. 2008, 1, 137–139. [Google Scholar] [CrossRef] [PubMed]
- Ferreira, C.; Silva, S.; Faria-Oliveira, F.; Pinho, E.; Henriques, M.; Lucas, C. Candida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p. BMC Microbiol. 2010, 10, 238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zarnowski, R.; Sanchez, H.; Covelli, A.S.; Dominguez, E.; Jaromin, A.; Berhardt, J.; Heiss, C.; Azadi, P.; Mitchell, A.; Andes, D.R. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. PLoS Biol. 2018, 16. [Google Scholar] [CrossRef] [PubMed]
- Ksiezopolska, E.; Gabaldon, T. Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens. Genes 2018, 9, 461. [Google Scholar] [CrossRef] [PubMed]
- Tanabe, K.; Bonus, M.; Tomiyama, S.; Miyoshi, K.; Nagi, M.; Niimi, K.; Chindamporn, A.; Gohlke, H.; Schmitt, L.; Cannon, R.D.; et al. FK506 resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 involves mutations in the transmembrane domains and extracellular loops. Antimicrob. Agents Chemother. 2018. [Google Scholar] [CrossRef] [PubMed]
- White, T.C.; Holleman, S.; Dy, F.; Mirels, L.F.; Stevens, D.A. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 2002, 46, 1704–1713. [Google Scholar] [CrossRef] [PubMed]
- Ostrosky-Zeichner, L.; Casadevall, A.; Galgiani, J.N.; Odds, F.C.; Rex, J.H. An insight into the antifungal pipeline: Selected new molecules and beyond. Nat. Rev. Drug Discov. 2010, 9, 719–727. [Google Scholar] [CrossRef] [PubMed]
- Rybowicz, J.; Gurk-Turner, C. Caspofungin: The first agent available in the echinocandin class of antifungals. Proc. (Bayl. Univ. Med. Cent.) 2002, 15, 97–99. [Google Scholar] [CrossRef] [PubMed]
- Balkovec, J.M.; Hughes, D.L.; Masurekar, P.S.; Sable, C.A.; Schwartz, R.E.; Singh, S.B. Discovery and development of first in class antifungal caspofungin (CANCIDAS(R.))—A case study. Nat. Prod. Rep. 2014, 31, 15–34. [Google Scholar] [CrossRef] [PubMed]
- Troskie, A.M.; Rautenbach, M.; Delattin, N.; Vosloo, J.A.; Dathe, M.; Cammue, B.P.; Thevissen, K. Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 2014, 58, 3697–3707. [Google Scholar] [CrossRef] [PubMed]
- Delattin, N.; De Brucker, K.; Vandamme, K.; Meert, E.; Marchand, A.; Chaltin, P.; Cammue, B.P.; Thevissen, K. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms. J. Antimicrob. Chemother. 2014, 69, 1035–1044. [Google Scholar] [CrossRef] [PubMed]
- Souza, A.C.R.; Fuchs, B.B.; Alves, V.S.; Jayamani, E.; Colombo, A.L.; Mylonakis, E. Pathogenesis of the Candida parapsilosis Complex in the Model Host Caenorhabditis elegans. Genes 2018, 9, 401. [Google Scholar] [CrossRef] [PubMed]
- Eschenauer, G.; Depestel, D.D.; Carver, P.L. Comparison of echinocandin antifungals. Ther. Clin. Risk Manag. 2007, 3, 71–97. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Barchiesi, F.; Spreghini, E.; Tomassetti, S.; Arzeni, D.; Giannini, D.; Scalise, G. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 2005, 49, 4989–4992. [Google Scholar] [CrossRef] [PubMed]
- Elefanti, A.; Mouton, J.W.; Krompa, K.; Al-Saigh, R.; Verweij, P.E.; Zerva, L.; Meletiadis, J. Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum. Antimicrob. Agents Chemother. 2013, 57, 1625–1631. [Google Scholar] [CrossRef] [PubMed]
- Walker, L.A.; Lee, K.K.; Munro, C.A.; Gow, N.A. Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies. Antimicrob. Agents Chemother. 2015, 59, 5932–5941. [Google Scholar] [CrossRef] [PubMed]
- Doman, M.; Kovacs, R.; Perlin, D.S.; Kardos, G.; Gesztelyi, R.; Juhasz, B.; Bozo, A.; Majoros, L. Dose escalation studies with caspofungin against Candida glabrata. J. Med. Microbiol. 2015, 64, 998–1007. [Google Scholar] [CrossRef] [PubMed]
- Walsh, T.J.; Teppler, H.; Donowitz, G.R.; Maertens, J.A.; Baden, L.R.; Dmoszynska, A.; Cornely, O.A.; Bourque, M.R.; Lupinacci, R.J.; Sable, C.A.; et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N. Engl. J. Med. 2004, 351, 1391–1402. [Google Scholar] [CrossRef] [PubMed]
- Maertens, J.; Raad, I.; Petrikkos, G.; Boogaerts, M.; Selleslag, D.; Petersen, F.B.; Sable, C.A.; Kartsonis, N.A.; Ngai, A.; Taylor, A.; et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin. Infect. Dis. 2004, 39, 1563–1571. [Google Scholar] [CrossRef] [PubMed]
- Tampakakis, E.; Okoli, I.; Mylonakis, E.A.C. C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds. Nat. Protoc. 2008, 3, 1925–1931. [Google Scholar] [CrossRef] [PubMed]
- Fazly, A.; Jain, C.; Dehner, A.C.; Issi, L.; Lilly, E.A.; Ali, A.; Cao, H.; Fidel, P.L., Jr.; Rao, R.P.; Kaufman, P.D. Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc. Natl. Acad. Sci. USA 2013, 110, 13594–13599. [Google Scholar] [CrossRef] [PubMed]
- Pukkila-Worley, R.; Mylonakis, E. From the outside in and the inside out: Antifungal immune responses in Caenorhabditis elegans. Virulence 2010, 1, 111–112. [Google Scholar] [CrossRef] [PubMed]
- Tardiff, D.F.; Tucci, M.L.; Caldwell, K.A.; Caldwell, G.A.; Lindquist, S. Different 8-hydroxyquinolines protect models of TDP-43 protein, alpha-synuclein, and polyglutamine proteotoxicity through distinct mechanisms. J. Biol. Chem. 2012, 287, 4107–4120. [Google Scholar] [CrossRef] [PubMed]
- Plaza, D.F.; Schmieder, S.S.; Lipzen, A.; Lindquist, E.; Künzler, M. Identification of a Novel Nematotoxic Protein by Challenging the Model Mushroom Coprinopsis cinerea with a Fungivorous Nematode. G3 (Bethesda) 2015, 6, 87–98. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Matlack, K.E.S.; Tardiff, D.F.; Narayan, P.; Hamamichi, S.; Caldwell, K.A.; Caldwell, G.A.; Lindquist, S. Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity. Proc. Natl. Acad. Sci. USA 2014, 111, 4013–4018. [Google Scholar] [CrossRef] [PubMed]
- Vargas-Blanco, D.; Lynn, A.; Rosch, J.; Noreldin, R.; Salerni, A.; Lambert, C.; Rao, R.P. A pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans. Ann. Clin. Microbiol. Antimicrob. 2017, 16, 41. [Google Scholar] [CrossRef] [PubMed]
- Chandra, J.; Kuhn, D.M.; Mukherjee, P.K.; Hoyer, L.L.; McCormick, T.; Ghannoum, M.A. Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J. Bacteriol. 2001, 183, 5385–5394. [Google Scholar] [CrossRef] [PubMed]
- Lu, Y.; Su, C.; Wang, A.; Liu, H. Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance. PLoS Biol. 2011, 9. [Google Scholar] [CrossRef]
- Hickman, M.A.; Zeng, G.; Forche, A.; Hirakawa, M.P.; Abbey, D.; Harrison, B.D.; Wang, Y.-M.; Su, C.-H.; Bennett, R.J.; Wang, Y.; et al. The ‘obligate diploid’ Candida albicans forms mating-competent haploids. Nature 2013, 494, 55–59. [Google Scholar] [CrossRef] [PubMed]
- Hickman, M.A.; Paulson, C.; Dudley, A.; Berman, J. Parasexual Ploidy Reduction Drives Population Heterogeneity Through Random and Transient Aneuploidy in Candida albicans. Genetics 2015, 200, 781–794. [Google Scholar] [CrossRef] [PubMed]
- Feistel, D.J.; Elmostafa, R.; Nguyen, N.; Penley, M.; Morran, L.; Hickman, M.A. A Novel Virulence Phenotype Rapidly Assesses Candida Fungal Pathogenesis in Healthy and Immunocompromised Caenorhabditis elegans Hosts. Available online: https://www.biorxiv.org/content/early/2018/07/16/370403 (accessed on 16 July 2018).
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Elkabti, A.B.; Issi, L.; Rao, R.P. Caenorhabditis elegans as a Model Host to Monitor the Candida Infection Processes. J. Fungi 2018, 4, 123. https://doi.org/10.3390/jof4040123
Elkabti AB, Issi L, Rao RP. Caenorhabditis elegans as a Model Host to Monitor the Candida Infection Processes. Journal of Fungi. 2018; 4(4):123. https://doi.org/10.3390/jof4040123
Chicago/Turabian StyleElkabti, Asmaa B., Luca Issi, and Reeta P. Rao. 2018. "Caenorhabditis elegans as a Model Host to Monitor the Candida Infection Processes" Journal of Fungi 4, no. 4: 123. https://doi.org/10.3390/jof4040123